Bullish case
$75 to $95
More likely if Celanese executes DuPont synergies, FCF remains above $1B, debt is reduced meaningfully, end-market demand recovers, and specialty polymers volume grows. This would support a higher earnings multiple.
Celanese Corporation research snapshot
CE AI Stock Analysis
CE AI stock analysis currently reads Celanese Corporation as a cyclical specialty chemicals producer with strong product positions, high debt from M&A, and recent TTM losses. The analysis is not a certain price prediction. At the July 12, 2026 cutoff, the latest verified close was $46.92 on July 10, 2026. Market capitalization was about $5.15 billion against an enterprise value of $16.29 billion. The main question was whether free cash flow recovery, acquisition synergies, and end-market demand can overcome a heavy debt load and negative earnings. This is informational research and not investment advice.
Current price
$46.92
Market cap
$5.15 billion
AI score
48 / 100
Rating
Turnaround chemicals business with high leverage
Trend status
Down from 52-week high, near lower end of range
Data cutoff (updated weekly)
July 12, 2026
Informational use only. This page is not investment advice.
Research quality check
- information Richness
- B-level information richness. Celanese has long public history, SEC filings, and moderate analyst coverage, but its acquisition-driven capital structure and recent losses make forward estimates more uncertain.
- bias Check
- The main AI bias risk is misplaced certainty in FCF recovery. TTM losses include impairment and restructuring charges that may not recur, but the debt load is structural. This page marks estimates with appropriate uncertainty.
- ai Confidence
- Medium-high data confidence on financials, lower on recovery timing
- investment Certainty
- Low. The chemicals cycle, integration execution, and high debt create wide outcome ranges. The business has durable product positions, but equity value is exposed to balance-sheet leverage.
Quick verdict table
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Celanese produces engineered polymers and acetyl chemicals with leading positions in POM, LCP, acetic acid, and VAM. Products serve auto, medical, electronics, and construction end markets. | Medium-high |
| Moat | Moat comes from proprietary polymer technology, long customer qualifications, integrated acetyl chain cost position, and brand heritage. Product switching costs are moderate to high in engineered materials. | Medium |
| Management | Management executed the large DuPont M&M acquisition and is focused on synergy delivery, debt reduction, and FCF generation. Acquisition timing near the cycle peak added leverage risk. | Medium |
| Financial trend | TTM revenue of $9.49 billion with negative net income of -$1.08 billion, driven by impairment charges and D&A from acquisitions. Levered FCF of $1.02 billion shows cash generation capacity. Debt-to-equity is 288%. | High |
| Valuation | At TTM P/E of -4.8x (losses), forward P/E of about 7.7x, EV/EBITDA of 42x, and P/FCF of 5x. The low forward P/E reflects earnings recovery expectations. Book value per share is about $36.90. | Medium |
| Technical trend | CE traded near $46.92, within the 52-week range of $35.13 to $70.70. Down 24.8% over the past year but up 11% year-to-date. Below the midpoint of its 52-week range. | Medium |
| Risk level | Elevated. High debt-to-equity of 288%, TTM losses, commodity chemical cyclicality, auto industry concentration, China/Asia demand exposure, and integration risk from DuPont M&M acquisition. | Medium-high |
| AI confidence | Medium-high confidence on balance sheet, revenue, and segment data. Lower confidence on near-term earnings recovery timing, impairment outlook, and chemical cycle direction. | Medium-high data confidence |
| Investment certainty | Low. High leverage and cyclical end markets make CE a high-risk name. A recovery thesis depends on debt reduction, FCF stability, and end-market demand. Not suitable for conservative portfolios without a wide margin of safety. | Low |
CE AI stock forecast
CE AI Stock Forecast Scenarios
The CE AI stock forecast uses scenario ranges around the $46.92 cutoff price. It does not claim that AI can predict a specific future price. The bullish case requires FCF recovery, debt reduction, and end-market stabilization. The base case assumes gradual improvement with ongoing leverage. The bearish case assumes prolonged earnings weakness and financial stress.
Base case
$40 to $60
More likely if earnings gradually normalize, leverage stays elevated but manageable, and the market prices CE near a mid-single-digit forward P/E with moderate FCF yield.
Bearish case
$25 to $35
More likely if recession or end-market downturn pressures volumes, impairments recur, debt covenants tighten, and the market prices CE at distressed levels reflecting balance-sheet risk.
CE AI technical analysis
CE AI Technical Analysis
CE AI technical analysis starts from the $46.92 July 10 close used for this July 12 static page. Public technical sources showed the stock well below its 52-week high and nearer the lower end of the range. Because this page does not fetch request-time market data, traders should confirm levels on a live chart before acting.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $46.92 | Latest verified close used for this page as of the July 12, 2026 data cutoff. |
| Near support | $42 to $44 | The area of recent trading lows. A hold above this zone suggests stabilization. |
| Secondary support | $35 to $36 | The 52-week low zone. A break below would signal a new lower trading range. |
| Near resistance | $52 to $55 | The area near the 50-day moving average and recent swing highs. |
| Key resistance | $65 to $70 | The upper end of the 52-week range. A recovery above this level would require significant fundamental catalysts. |
| 52-week range | $35.13 to $70.70 | CE trades at about 43% of the range from the low, indicating a mid-to-low range position. |
| Volume | About 1.08 million shares | Below the average volume of 1.96 million, suggesting reduced participation. |
| Volatility | Beta 0.76, 52-week range width of 101% | Beta below 1.0 suggests lower volatility than the market, but the wide 52-week range reflects company-specific risk. |
| Momentum | YTD up 11%, 1Y down 25% | Year-to-date positive but negative over the past year. Mixed momentum signals. |
| Invalidation | Close below $42 or sustained below $35 | A close below $42 weakens the near-term outlook. A break below $35 would challenge the whole recovery thesis. |
CE AI trading strategy
CE AI Trading Strategy Framework
The CE AI trading strategy is a rules-based framework, not personalized advice. It combines business-cycle awareness, valuation check, technical confirmation, position sizing, and clear invalidation levels.
Event-driven setup
Monitor Q2 2026 earnings on August 4-5, 2026 for FCF, revenue trends, debt paydown progress, and forward guidance. An earnings beat with improved guidance could trigger a re-rating.
Do not position ahead of earnings without defined stop. CE can move sharply on earnings given its high fixed-cost base and leverage.
Mean-reversion setup
If CE pulls back toward $42 to $44 support with no thesis break, look for price stabilization, insider buying, or volume exhaustion as confirming signals before considering a position.
Position size must reflect the elevated balance-sheet risk. Define maximum loss based on a close below $40.
Fundamental monitor
Track quarterly free cash flow, net debt/EBITDA ratio, DuPont synergy realization, end-market demand, and impairment charges. The key metric is whether CE generates enough FCF to reduce debt while maintaining operations.
Reduce exposure if debt increases, FCF turns negative, or end-market demand shows sustained deterioration.
Investment research summary
Four-master Research Compression
Business essence
Celanese converts commodity acetyl feedstocks and engineered polymer technology into specialty materials that customers qualify into automotive, medical, electronics, and industrial products over multi-year cycles.
Moat
The moat comes from proprietary polymer technology (POM, LCP, UHMW-PE), long product qualification cycles, integrated acetyl chain cost advantages, and brand heritage with trusted trademarks like Celcon, Hostaform, and Vectra.
Munger risk inversion
The thesis can fail if demand from auto, electronics, or construction weakens, integration from the DuPont M&M acquisition falls short, high debt restricts financial flexibility, impairments recur, or a recession pressures chemical margins broadly.
Management
Management pursued the $11 billion DuPont M&M acquisition in 2022 to transform Celanese into a larger engineered materials player. Synergy delivery and debt reduction are now the focus. Key-person risk is moderate given the management depth.
Industry trend
Specialty chemicals demand is tied to industrial production, auto builds, electronics, and construction. The industry is mature but offers niche growth in engineering plastics, lightweight materials, and sustainability-focused products like CO2-based POM.
Valuation and margin of safety
At a $46.92 price, 288% debt-to-equity, and negative TTM earnings, CE offers no clear margin of safety for conservative investors. A forward P/E of 7.7x and 5x P/FCF suggest the market expects recovery, but high leverage leaves equity exposed to adverse scenarios.
Source-backed data
CE Data Table
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| CE price | $46.92 close on July 10, 2026 | Yahoo Finance and Business Insider quote snapshots | July 12, 2026 |
| Market capitalization | $5.15 billion, verified as $46.92 x 109.7 million shares | financial_rigor.py market cap verification | July 12, 2026 |
| Enterprise value | $16.29 billion | Yahoo Finance statistics | July 12, 2026 |
| Revenue (TTM) | $9.49 billion | Yahoo Finance, cross-validated | July 12, 2026 |
| Net income (TTM) | -$1.08 billion | Yahoo Finance | July 12, 2026 |
| Diluted EPS (TTM) | -$9.86 | Yahoo Finance | July 12, 2026 |
| Cash and cash equivalents | $1.76 billion | Yahoo Finance, cross-validated | July 12, 2026 |
| Total debt/equity | 287.74% | Yahoo Finance | July 12, 2026 |
| Levered free cash flow (TTM) | $1.02 billion | Yahoo Finance | July 12, 2026 |
| Forward P/E | 7.74x | Yahoo Finance | July 12, 2026 |
| Book value per share | Approximately $36.90 | Calculated from equity / shares outstanding | July 12, 2026 |
| Valuation math | TTM P/E -4.76x, P/B 1.27x, P/FCF 5.05x, FCF yield 19.82% from financial_rigor.py | financial_rigor.py valuation verification | July 12, 2026 |
Frequently Asked Questions
Read the DOW AI stock analysisView LYB AI stock forecastExplore AI Stock PickerGenerate an AI trading strategy
This CE AI stock analysis is an informational tool for research and education only. It is not investment advice, a recommendation, or a guarantee of future performance. Forecast ranges are scenarios based on available data as of July 12, 2026 and can be wrong. Chemicals businesses are cyclical, and leverage introduces additional risk.
Related Tools
Trading Strategy Builder
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Try it
Stock Screener
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Try it
AI Stock Picker & Screener
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
Try it